High-dose sequential chemotherapy coupled with autologous PBSCT and in vivo purging with rituximab in patients with relapsed/refractory or high-risk B-cell NHL

被引：0
|
作者：
Oyan, B [1 ]
Koc, Y [1 ]
Ozdemir, E [1 ]
Kansu, E [1 ]
机构：
[1] Univ Hacettepe, Ankara, Turkey
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S385 / S385
页数：1
相关论文
共 50 条
  • [1] Successful salvage with high-dose sequential chemotherapy coupled with autologous PBSCT and in vivo purging with Rituximab in patients with primary refractory mantle cell lymphoma presenting in leukemic phase.
    Oyan, B
    Koc, Y
    Tekin, F
    Kansu, E
    BLOOD, 2002, 100 (11) : 471B - 471B
  • [2] Rituximab as in vivo purging agent in autologous stem cell transplantation for relapsed B-NHL
    Hess, G
    Flohr, T
    Derigs, HG
    ANNALS OF HEMATOLOGY, 2002, 81 : S54 - S55
  • [3] Mabtera (rituximab) treatment of patients with refractory B-cell lymphomas on high-dose chemotherapy with autologous transplantation of hemopoiesis precursor cells
    Ptushkin, VV
    Chimishkyan, KL
    Zhukov, NV
    Osmanov, DS
    Andreeva, LY
    Tupitsyn, NN
    Larionova, VB
    Mkheidze, DM
    Poddubnaya, IV
    TERAPEVTICHESKII ARKHIV, 2003, 75 (01) : 65 - 68
  • [4] High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma
    Alkhaldi, Hanan
    Reinhardt, Alec
    Barnett, Melissa
    Kundu, Suprateek
    Hosing, Chitra
    Ramdial, Jeremy
    Saini, Neeraj
    Srour, Samer
    Alousi, Amin
    Kebriaei, Partow
    Popat, Uday
    Qazilbash, Muzaffar
    Champlin, Richard
    Shpall, Elizabeth J.
    Gulbis, Allison
    Shigle, Terri Lynn
    Dabaja, Bouthaina
    Pinnix, Chelsea
    Ahmed, Sairah
    Steiner, Raphael
    Andersson, Borje S.
    Nieto, Yago
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (11): : 690 - 694
  • [5] Multicentre phase II trial of 90Y-ibritumomab tiuxetan with high-dose chemotherapy (busulfan/cyclophosphamide/etoposide) followed by autologous stem cell transplantation in relapsed, refractory, or high-risk B-cell NHL
    Kang, B. W.
    Kim, S.
    Cho, Y. H.
    Ryu, J. -S.
    Kim, W. S.
    Yoon, S. S.
    Suh, C.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S248 - S248
  • [6] Concurrent administration of rituximab and high dose chemotherapy supported by autologous peripheral blood stem cell (ASCT) as in vivo purging for relapsed or high-risk non-Hodgkin lymphoma
    Stefani, P. M.
    Salvadon, U.
    Gottardi, M.
    Zanetti, F.
    Danesin, D.
    Sartor, D.
    Agostini, P.
    Cavallin, S.
    Calistri, E.
    Gherlinzoni, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 224 - 224
  • [7] High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma
    Oyan, Basak
    Koc, Yener
    Ozdemir, Evren
    Kars, Ayse
    Turker, Alev
    Tekuzman, Gulten
    Kansu, Emin
    LEUKEMIA & LYMPHOMA, 2006, 47 (08) : 1545 - 1552
  • [8] Successful Salvage with High-Dose Sequential Chemotherapy Coupled with In Vivo Purging and Autologous Stem Cell Transplantation in 2 Patients with Primary Refractory Mantle Cell Lymphoma Presenting in the Leukemic Phase
    Basak Oyan
    Yener Koc
    Esmin Kansu
    International Journal of Hematology, 2005, 81 : 155 - 158
  • [9] Successful salvage with high-dose sequential chemotherapy coupled with in vivo purging and autologous stem cell transplantation in 2 patients with primary refractory mantle cell lymphoma presenting in the leukemic phase
    Oyan, B
    Koc, Y
    Kansu, E
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 81 (02) : 155 - 158
  • [10] Efficiency of in vivo purging with rituximab followed by high-dose therapy (HDT) with autologous peripheral blood stem cell transplantation (PBSCT) in B-cell lymphomas. A single center study
    Belhadj, K
    Delfau-Larue, MH
    Elgnaoui, T
    Beaujean, F
    Beaumont, JL
    Pautas, C
    Gaillard, I
    Kirova, Y
    Allain, A
    Gaulard, P
    Farcet, JP
    Reyes, F
    Haioun, C
    BONE MARROW TRANSPLANTATION, 2002, 29 : S89 - S89
12345